UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of June 2025
Commission File Number: 001-41411
Haleon plc
(Translation
of registrant’s name into English)
Building 5, First Floor, The Heights,
Weybridge, Surrey, KT13 0NY
(Address
of principal executive offices)
Indicate
by check mark whether the registrant files or will file annual
reports under cover of Form 20-F or Form 40-F:
|
|
Form
20-F ☒
|
Form
40-F ☐
|
|
EXHIBIT INDEX
|
Exhibit
Number
|
Description
|
|
99.1
|
11 June
2025 - “Director/PDMR Shareholding”
|
99.1
Haleon plc: Director/PDMR
Shareholding
11 June
2025: Haleon
plc (the "Company" or "Haleon") (LSE/NYSE:HLN) today announces
notification and public disclosure in accordance with the
requirements of The UK Market Abuse Regulation of Transactions by
Persons Discharging Managerial Responsibilities
("PDMRs").
On 10 June 2025, the Company was notified of the following
transactions as detailed below.
|
1
|
Details of the person discharging managerial responsibilities /
person closely associated
|
|||||
|
a)
|
Name
|
Keith Choy
|
||||
|
2
|
Reason for the notification
|
|||||
|
a)
|
Position/status
|
President, Asia Pacific - PDMR
|
||||
|
b)
|
Initial notification /Amendment
|
Initial Notification
|
||||
|
3
|
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction
monitor
|
|||||
|
a)
|
Name
|
Haleon plc
|
||||
|
b)
|
LEI
|
549300PSB3WWEODCUP19
|
||||
|
4
|
Details of the transaction(s): section to be repeated for (i) each
type of instrument; (ii) each type of transaction; (iii) each date;
and (iv) each place where transactions have been
conducted
|
|||||
|
a)
|
Description of the financial instrument, type of
instrument
Identification code
|
Ordinary Shares of £0.01 each
GB00BMX86B70
|
||||
|
b)
|
Nature of the transaction
|
Sale of Ordinary Shares in the Company
|
||||
|
c)
|
Price(s) and volume(s)
|
|
|
|
|
|
|
|
|
Price(s)
|
Volume(s)
|
|
||
|
|
|
£4.000837
|
45,000
|
|
||
|
|
|
|
|
|
||
|
d)
|
Aggregated information
|
N/A
|
||||
|
|
|
|||||
|
- Aggregated volume
|
|
|||||
|
|
|
|||||
|
- Price
|
|
|||||
|
|
|
|||||
|
e)
|
Date of the transaction
|
9 June 2025
|
||||
|
f)
|
Place of the transaction
|
London Stock Exchange (XLON)
|
||||
|
4
|
Details of the transaction(s): section to be repeated for (i) each
type of instrument; (ii) each type of transaction; (iii) each date;
and (iv) each place where transactions have been
conducted
|
|||||
|
a)
|
Description of the financial instrument, type of
instrument
Identification code
|
Ordinary Shares of £0.01 each
GB00BMX86B70
|
||||
|
b)
|
Nature of the transaction
|
Sale of Ordinary Shares in the Company
|
||||
|
c)
|
Price(s) and volume(s)
|
|
|
|
|
|
|
|
|
Price(s)
|
Volume(s)
|
|
||
|
|
|
£3.989713
|
20,000
|
|
||
|
|
|
£3.953695
|
20,000
|
|
||
|
|
|
|
|
|
||
|
d)
|
Aggregated information
|
|
||||
|
|
|
|||||
|
- Aggregated volume
|
40,000
|
|||||
|
|
|
|||||
|
- Price
|
£3.971704
|
|||||
|
|
|
|||||
|
e)
|
Date of the transaction
|
10 June 2025
|
||||
|
f)
|
Place of the transaction
|
London Stock Exchange (XLON)
|
||||
|
1
|
Details of the person discharging managerial responsibilities /
person closely associated
|
||||
|
a)
|
Name
|
Alan Stewart
|
|||
|
2
|
Reason for the notification
|
||||
|
a)
|
Position/status
|
Independent Non-Executive Director - PDMR
|
|||
|
b)
|
Initial notification /Amendment
|
Initial Notification
|
|||
|
3
|
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction
monitor
|
||||
|
a)
|
Name
|
Haleon plc
|
|||
|
b)
|
LEI
|
549300PSB3WWEODCUP19
|
|||
|
4
|
Details of the transaction(s): section to be repeated for (i) each
type of instrument; (ii) each type of transaction; (iii) each date;
and (iv) each place where transactions have been
conducted
|
||||
|
a)
|
Description of the financial instrument, type of
instrument
Identification code
|
Ordinary Shares of £0.01 each
GB00BMX86B70
|
|||
|
b)
|
Nature of the transaction
|
Acquisition of Ordinary Shares as a result of dividend
reinvestment
|
|||
|
c)
|
Price(s) and volume(s)
|
|
|
|
|
|
|
|
Price(s)
|
Volume(s)
|
|
|
|
|
|
£4.039904
|
376
|
|
|
|
|
|
|
|
|
|
|
d)
|
Aggregated information
|
N/A
|
|||
|
|
|
||||
|
- Aggregated volume
|
|
||||
|
|
|
||||
|
- Price
|
|
||||
|
|
|
||||
|
e)
|
Date of the transaction
|
5 June 2025
|
|||
|
f)
|
Place of the transaction
|
London Stock Exchange (XLON)
|
|||
On 11 June 2025, the Company was notified of the following
transactions as detailed below.
|
1
|
Details of the person discharging managerial responsibilities /
person closely associated
|
||||
|
a)
|
Name
|
Dawn Allen
|
|||
|
2
|
Reason for the notification
|
||||
|
a)
|
Position/status
|
Chief Financial Officer - PDMR
|
|||
|
b)
|
Initial notification /Amendment
|
Initial Notification
|
|||
|
3
|
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction
monitor
|
||||
|
a)
|
Name
|
Haleon plc
|
|||
|
b)
|
LEI
|
549300PSB3WWEODCUP19
|
|||
|
4
|
Details of the transaction(s): section to be repeated for (i) each
type of instrument; (ii) each type of transaction; (iii) each date;
and (iv) each place where transactions have been
conducted
|
||||
|
a)
|
Description of the financial instrument, type of
instrument
Identification code
|
Ordinary Shares of £0.01 each
GB00BMX86B70
|
|||
|
b)
|
Nature of the transaction
|
Acquisition of Ordinary Shares as a result of dividend
reinvestment
|
|||
|
c)
|
Price(s) and volume(s)
|
|
|
|
|
|
|
|
Price(s)
|
Volume(s)
|
|
|
|
|
|
£3.9654
|
974.12802
|
|
|
|
|
|
|
|
|
|
|
d)
|
Aggregated information
|
N/A
|
|||
|
|
|
||||
|
- Aggregated volume
|
|
||||
|
|
|
||||
|
- Price
|
|
||||
|
|
|
||||
|
e)
|
Date of the transaction
|
10 June 2025
|
|||
|
f)
|
Place of the transaction
|
London Stock Exchange (XLON)
|
|||
|
1
|
Details of the person discharging managerial responsibilities /
person closely associated
|
||||
|
a)
|
Name
|
Keith Choy
|
|||
|
2
|
Reason for the notification
|
||||
|
a)
|
Position/status
|
President, Asia Pacific - PDMR
|
|||
|
b)
|
Initial notification /Amendment
|
Initial Notification
|
|||
|
3
|
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction
monitor
|
||||
|
a)
|
Name
|
Haleon plc
|
|||
|
b)
|
LEI
|
549300PSB3WWEODCUP19
|
|||
|
4
|
Details of the transaction(s): section to be repeated for (i) each
type of instrument; (ii) each type of transaction; (iii) each date;
and (iv) each place where transactions have been
conducted
|
||||
|
a)
|
Description of the financial instrument, type of
instrument
|
Ordinary Shares of £0.01 each
|
|||
|
|
|
||||
|
Identification code
|
GB00BMX86B70
|
||||
|
|
|
||||
|
b)
|
Nature of the transaction
|
Acquisition of Ordinary Shares as a result of dividend
reinvestment
|
|||
|
c)
|
Price(s) and volume(s)
|
|
|
|
|
|
|
|
Price(s)
|
Volume(s)
|
|
|
|
|
|
£3.9654
|
7462.44922
|
|
|
|
|
|
|
|
|
|
|
d)
|
Aggregated information
|
N/A
|
|||
|
|
|
||||
|
- Aggregated volume
|
|
||||
|
|
|
||||
|
- Price
|
|
||||
|
|
|
||||
|
e)
|
Date of the transaction
|
10 June 2025
|
|||
|
f)
|
Place of the transaction
|
London Stock Exchange (XLON)
|
|||
|
1
|
Details of the person discharging managerial responsibilities /
person closely associated
|
||||
|
a)
|
Name
|
Filippo Lanzi
|
|||
|
2
|
Reason for the notification
|
||||
|
a)
|
Position/status
|
President, EMEA and LATAM - PDMR
|
|||
|
b)
|
Initial notification /Amendment
|
Initial Notification
|
|||
|
3
|
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction
monitor
|
||||
|
a)
|
Name
|
Haleon plc
|
|||
|
b)
|
LEI
|
549300PSB3WWEODCUP19
|
|||
|
4
|
Details of the transaction(s): section to be repeated for (i) each
type of instrument; (ii) each type of transaction; (iii) each date;
and (iv) each place where transactions have been
conducted
|
||||
|
a)
|
Description of the financial instrument, type of
instrument
Identification code
|
Ordinary Shares of £0.01 each
GB00BMX86B70
|
|||
|
b)
|
Nature of the transaction
|
Acquisition of Ordinary Shares as a result of dividend
reinvestment
|
|||
|
c)
|
Price(s) and volume(s)
|
|
|
|
|
|
|
|
Price(s)
|
Volume(s)
|
|
|
|
|
|
£3.9654
|
4077.39218
|
|
|
|
|
|
|
|
|
|
|
d)
|
Aggregated information
|
N/A
|
|||
|
|
|
||||
|
- Aggregated volume
|
|
||||
|
|
|
||||
|
- Price
|
|
||||
|
|
|
||||
|
e)
|
Date of the transaction
|
10 June 2025
|
|||
|
f)
|
Place of the transaction
|
London Stock Exchange (XLON)
|
|||
|
1
|
Details of the person discharging managerial responsibilities /
person closely associated
|
|||||||
|
a)
|
Name
|
Brian McNamara
|
||||||
|
2
|
Reason for the notification
|
|||||||
|
a)
|
Position/status
|
Chief Executive Officer - PDMR
|
||||||
|
b)
|
Initial notification /Amendment
|
Initial Notification
|
||||||
|
3
|
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction
monitor
|
|||||||
|
a)
|
Name
|
Haleon plc
|
||||||
|
b)
|
LEI
|
549300PSB3WWEODCUP19
|
||||||
|
4
|
Details of the transaction(s): section to be repeated for (i) each
type of instrument; (ii) each type of transaction; (iii) each date;
and (iv) each place where transactions have been
conducted
|
|||||||
|
a)
|
Description of the financial instrument, type of
instrument
Identification code
|
Ordinary Shares of £0.01 each
GB00BMX86B70
|
||||||
|
b)
|
Nature of the transaction
|
Acquisition of Ordinary Shares as a result of dividend
reinvestment
|
||||||
|
c)
|
Price(s) and volume(s)
|
|
|
|
|
|||
|
|
|
|
Price(s)
|
Volume(s)
|
|
|||
|
|
|
|
£3.9654
|
9851.75193
|
|
|||
|
|
|
|
|
|
|
|||
|
d)
|
Aggregated information
|
N/A
|
||||||
|
|
|
|||||||
|
- Aggregated volume
|
|
|||||||
|
|
|
|||||||
|
- Price
|
|
|||||||
|
|
|
|||||||
|
e)
|
Date of the transaction
|
10 June 2025
|
||||||
|
f)
|
Place of the transaction
|
London Stock Exchange (XLON)
|
||||||
|
4
|
Details of the transaction(s): section to be repeated for (i) each
type of instrument; (ii) each type of transaction; (iii) each date;
and (iv) each place where transactions have been
conducted
|
|||||||
|
a)
|
Description of the financial instrument, type of
instrument
Identification code
|
Haleon plc American Depositary Shares (ADS)
US4055521003
|
||||||
|
b)
|
Nature of the transaction
|
Acquisition of ADSs as
a result of dividend reinvestment
|
||||||
|
c)
|
Price(s) and volume(s)
|
|
|
|
|
|||
|
|
|
Price(s)
|
Volume(s)
|
|
||||
|
|
|
$10.8692
|
3639.49143
|
|
||||
|
|
|
|
|
|
||||
|
d)
|
Aggregated information
|
N/A
|
||||||
|
|
|
|||||||
|
- Aggregated volume
|
|
|||||||
|
|
|
|||||||
|
- Price
|
|
|||||||
|
|
|
|||||||
|
e)
|
Date of the transaction
|
10 June 2025
|
||||||
|
f)
|
Place of the transaction
|
New York Stock Exchange (XNYS)
|
||||||
|
1
|
Details of the person discharging managerial responsibilities /
person closely associated
|
||||
|
a)
|
Name
|
Adrian Morris
|
|||
|
2
|
Reason for the notification
|
||||
|
a)
|
Position/status
|
General Counsel - PDMR
|
|||
|
b)
|
Initial notification /Amendment
|
Initial Notification
|
|||
|
3
|
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction
monitor
|
||||
|
a)
|
Name
|
Haleon plc
|
|||
|
b)
|
LEI
|
549300PSB3WWEODCUP19
|
|||
|
4
|
Details of the transaction(s): section to be repeated for (i) each
type of instrument; (ii) each type of transaction; (iii) each date;
and (iv) each place where transactions have been
conducted
|
||||
|
a)
|
Description of the financial instrument, type of
instrument
|
Ordinary Shares of £0.01 each
|
|||
|
|
|
||||
|
Identification code
|
GB00BMX86B70
|
||||
|
|
|
||||
|
b)
|
Nature of the transaction
|
Acquisition of Partnership Shares and award of Matching Shares
under the Company's Share Reward Plan
|
|||
|
c)
|
Price(s) and volume(s)
|
|
|
|
|
|
|
|
Price(s)
|
Volume(s)
|
|
|
|
|
|
£3.9619
|
32
|
|
|
|
|
|
£Nil
|
32 (Matching Shares)
|
|
|
|
|
|
|
|
|
|
|
d)
|
Aggregated information
|
|
|||
|
|
|
||||
|
- Aggregated volume
|
64
|
||||
|
|
|
||||
|
- Price
|
|
||||
|
|
|
||||
|
e)
|
Date of the transaction
|
10 June 2025
|
|||
|
f)
|
Place of the transaction
|
London Stock Exchange (XLON)
|
|||
|
1
|
Details of the person discharging managerial responsibilities /
person closely associated
|
||||
|
a)
|
Name
|
Franck Riot
|
|||
|
2
|
Reason for the notification
|
||||
|
a)
|
Position/status
|
Chief R&D Officer - PDMR
|
|||
|
b)
|
Initial notification /Amendment
|
Initial Notification
|
|||
|
3
|
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction
monitor
|
||||
|
a)
|
Name
|
Haleon plc
|
|||
|
b)
|
LEI
|
549300PSB3WWEODCUP19
|
|||
|
4
|
Details of the transaction(s): section to be repeated for (i) each
type of instrument; (ii) each type of transaction; (iii) each date;
and (iv) each place where transactions have been
conducted
|
||||
|
a)
|
Description of the financial instrument, type of
instrument
Identification code
|
Ordinary Shares of £0.01 each
GB00BMX86B70
|
|||
|
b)
|
Nature of the transaction
|
Acquisition of Ordinary Shares as a result of dividend
reinvestment
|
|||
|
c)
|
Price(s) and volume(s)
|
|
|
|
|
|
|
|
Price(s)
|
Volume(s)
|
|
|
|
|
|
£3.9654
|
2670.66966
|
|
|
|
|
|
|
|
|
|
|
d)
|
Aggregated information
|
N/A
|
|||
|
|
|
||||
|
- Aggregated volume
|
|
||||
|
|
|
||||
|
- Price
|
|
||||
|
|
|
||||
|
e)
|
Date of the transaction
|
10 June 2025
|
|||
|
f)
|
Place of the transaction
|
London Stock Exchange (XLON)
|
|||
|
1
|
Details of the person discharging managerial responsibilities /
person closely associated
|
|||||
|
a)
|
Name
|
Tamara Rogers
|
||||
|
2
|
Reason for the notification
|
|||||
|
a)
|
Position/status
|
Chief Marketing Officer - PDMR
|
||||
|
b)
|
Initial notification /Amendment
|
Initial Notification
|
||||
|
3
|
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction
monitor
|
|||||
|
a)
|
Name
|
Haleon plc
|
||||
|
b)
|
LEI
|
549300PSB3WWEODCUP19
|
||||
|
4
|
Details of the transaction(s): section to be repeated for (i) each
type of instrument; (ii) each type of transaction; (iii) each date;
and (iv) each place where transactions have been
conducted
|
|||||
|
a)
|
Description of the financial instrument, type of
instrument
Identification code
|
Ordinary Shares of £0.01 each
GB00BMX86B70
|
||||
|
b)
|
Nature of the transaction
|
Acquisition of Ordinary Shares as a result of dividend
reinvestment
|
||||
|
c)
|
Price(s) and volume(s)
|
|
|
|
|
|
|
|
|
Price(s)
|
Volume(s)
|
|
||
|
|
|
£3.9654
|
3298.23924
|
|
||
|
|
|
|
|
|
||
|
d)
|
Aggregated information
|
N/A
|
||||
|
|
|
|||||
|
- Aggregated volume
|
|
|||||
|
|
|
|||||
|
- Price
|
|
|||||
|
|
|
|||||
|
e)
|
Date of the transaction
|
10 June 2025
|
||||
|
f)
|
Place of the transaction
|
London Stock Exchange (XLON)
|
||||
|
4
|
Details of the transaction(s): section to be repeated for (i) each
type of instrument; (ii) each type of transaction; (iii) each date;
and (iv) each place where transactions have been
conducted
|
|||||
|
a)
|
Description of the financial instrument, type of
instrument
|
Ordinary Shares of £0.01 each
|
||||
|
|
||||||
|
Identification code
|
GB00BMX86B70
|
|||||
|
|
|
|||||
|
b)
|
Nature of the transaction
|
Acquisition of Partnership Shares and award of Matching Shares
under the Company's Share Reward Plan
|
||||
|
c)
|
Price(s) and volume(s)
|
|
|
|
|
|
|
|
|
Price(s)
|
Volume(s)
|
|
||
|
|
|
£3.9619
|
32
|
|
||
|
|
|
£Nil
|
32 (Matching Shares)
|
|
||
|
|
|
|
|
|
||
|
d)
|
Aggregated information
|
|
||||
|
|
|
|||||
|
- Aggregated volume
|
64
|
|||||
|
|
|
|||||
|
- Price
|
|
|||||
|
|
|
|||||
|
e)
|
Date of the transaction
|
10 June 2025
|
||||
|
f)
|
Place of the transaction
|
London Stock Exchange (XLON)
|
||||
Amanda Mellor
Company Secretary
About Haleon
Haleon (LSE/NYSE: HLN) is a global leader in consumer health, with
a purpose to deliver better everyday health with humanity. Haleon's
product portfolio spans six major categories - Oral Health,
Vitamins, Minerals and Supplements (VMS), Pain Relief, Respiratory
Health, Digestive Health and Therapeutic Skin Health and Other. Its
long-standing brands - such as Advil, Centrum, Otrivin,
Panadol, parodontax, Polident, Sensodyne,
Theraflu and Voltaren - are built on trusted science, innovation
and deep human understanding.
For more information, please visit www.haleon.com.
SIGNATURE
Pursuant
to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf
by the undersigned, thereunto duly authorized.
|
|
|
HALEON PLC
(Registrant)
|
|
|
Date:
June 11, 2025
|
By:
|
/s/
Amanda Mellor
|
|
|
|
|
Name:
|
Amanda
Mellor
|
|
|
|
Title:
|
Company
Secretary
|